Back to Journals » Drug Design, Development and Therapy » Volume 12

Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer

Total article views   HTML views PDF downloads Totals
31,744 Dovepress* 19,607+ 2,794 22,401
PubMed Central* 12,137 2,026 14,163
Totals 31,744 4,820 36,564
*Since 16 February 2018
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 1 6

View citations on PubMed and Google Scholar